Retasturtide is a recently launched novel GLP-1 receptor agonist demonstrating encouraging results in the treatment of type 2 diabetes. This synthetic peptide duplicates the actions of naturally present GLP-1, a hormone that plays a crucial role in regulating blood insulin response. By activating GLP-1 receptors in the pancreas, Retasturtide promo